Response to direct acting antivirals in vertically HIV/HCV co-infected youths

被引：0

作者：

Carrasco, I. ^{[1
]}

Sainz, T. ^{[2
]}

Frick, M. A. ^{[3
]}

Jimenez de Ory, S. ^{[1
]}

Montero, M. ^{[4
]}

Gavilan, C. ^{[5
]}

Falcon, M. D. ^{[6
]}

Couceiro, J. A. ^{[7
]}

Bernardino, J. I. ^{[2
]}

Rubio, R. ^{[8
]}

Bisbal, O. ^{[8
]}

Guerrero, C. ^{[9
]}

Aldamiz-Echevarria, M. T. ^{[1
]}

Miralles, P. ^{[1
]}

Berenguer, J. ^{[1
]}

Navarro, M. L. ^{[1
]}

机构：

[1] IiSGM Gregorio Maranon Univ Hosp, Madrid, Spain

[2] La Paz Univ Hosp, Madrid, Spain

[3] Vall dHebron Univ Hosp, Barcelona, Spain

[4] La Fe Univ & Polytech Hosp, Valencia, Spain

[5] San Juan de Alicante Hosp, Alicante, Spain

[6] Virgen del Rocio Univ Hosp, Seville, Spain

[7] Pontevedra Hosp Complex, Pontevedra, Spain

[8] 12 Octubre Hosp, Madrid, Spain

[9] Miguel Servet Univ Hosp, Madrid, Spain

来源：

JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2019年 / 22卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

WEAB0205

引用

页码：48 / 48

页数：1

共 50 条

[21] Safety and efficacy of directly acting antivirals (sofosbuvir and daclatasvir) in treatment of chronic HCV in HIV-HCV co-infected Egyptian patients
Inas E L-Khedr Mohamed
Kadry Mohamed EL-Saeed
Mahmoud Hassan Al-Sadik
Christina Alphonse Anwar
Egyptian Liver Journal, 11
[22] Evaluation of Immune Function, Renal Function, and Glycemic Control in HIV/HCV Co-Infected Patients Successfully Treated for Chronic HCV with Direct-Acting Antivirals.
Patel, Sonali K.
Patel, Manish
Kriengkauykiat, Jane
Miller, Lesley
HEPATOLOGY, 2018, 68 : 602A - 602A
[23] First Real Life Evidence of New Direct-acting Antivirals (DAA) in Co-infected HIV HCV Patients: Better than Ever Reply
Shafran, Stephen D.
CLINICAL INFECTIOUS DISEASES, 2016, 62 (07) : 949 - +
[24] Risk of HIV viral rebound in HIV infected patients on direct acting antivirals (DAAs) treatment for HCV
Morsica, Giulia
Galli, Laura
Messina, Emanuela
Castagna, Antonella
Bagaglio, Sabrina
Salpietro, Stefania
Liviana, Della Torre
Uberti-Foppa, Caterina
Hasson, Hamid
PLOS ONE, 2022, 17 (02):
[25] Directly active antivirals pharmacokinetics in HCV/HIV co-infected patients with advanced hepatic fibrosis
Marinaro, L.
Merli, M.
Barco, A.
Alcantarini, C.
Montrucchio, C.
Tettoni, M. C.
Vendemiati, G.
Bocchino, G.
De Nicolo, A.
Hasson, H.
D'Avolio, A.
Foppa, C. U.
Di Perri, G.
Bonora, S.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S534 - S534
[26] MicroRNAs Profiling in HIV, HCV, and HIV/HCV Co-Infected Patients
Moghoofei, Mohsen
Najafipour, Sohrab
Mostafaei, Shayan
Tavakoli, Ahmad
Bokharaei-Salim, Farah
Ghorbani, Saied
Javanmard, Davod
Ghaffari, Hadi
Monavari, Seyed Hamidreza
CURRENT HIV RESEARCH, 2021, 19 (01) : 27 - 34
[27] Safety profile of direct-acting antivirals based therapy in HCV mono and co-infected patients in a real-world setting
Campos-Davila, E.
Tellez-Perez, F.
Guerra-Estevez, D.
Ramos-Baez, J. J.
Roldan-Morales, J. C.
Villanueva, P.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2016, 38 (02) : 574 - 574
[28] Direct-acting antivirals and hepatitis B virus (HBV) reactivation in co-infected HBV/HCV kidney-transplant recipients
Pol, Stanislas
Marion, Olivier
Vallet-Pichard, Anais
Meritet, Jean-Francois
Saune, Karine
Alric, Laurent
Kamar, Nassim
TRANSPLANT INFECTIOUS DISEASE, 2018, 20 (03)
[29] FIB-4 variation in HIV/HCV co-infected patients treated with DAAs (direct-acting antivirals) with SVR12: a MaSTER cohort study
Nasta, P.
Giralda, M.
Odolini, S.
Urbinati, L.
Maggiolo, F.
Digianbenedetto, S.
Ladisa, N.
Di Pietro, M.
Gori, A.
Zacchi, F.
Castelli, F.
JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S728 - S728
[30] Rectal Shedding of HCV in HCV/HIV Co-infected Men
Foster, Andrew L.
Gaisa, Michael
Hijdra, Rosanne M.
Jacobson, Karen B.
Turner, Samuel
Morey, Tristan
Fierer, Daniel S.
HEPATOLOGY, 2015, 62 : 253A - 253A

← 1 2 3 4 5 →